Hochman, J.S.

patient study trial eptifibatide infarction event death atrial fi brillation state point lp-pla 2 activity pursuit revascularization stroke 30 days treatment solid-timi 52 trial darapladib lp-pla end point subject therapy elevation placebo heart month treatment effect group effect activity solid-timi ischemic randomized st-segment atrial disease syndrome randomization outcome 0.001 management non-us patients angina eptifibatide therapy nonfatal end points brillation nonfatal mi timi study group non-u 6 months st-segment elevation /iiia plaque circulation hospital incidence lipoprotein-associated phospholipase procedure efficacy table lp-pla 2 cv death infusion surgery atherosclerotic platelet baseline biomarker reduction glycoprotein benefit study drug infusion patients randomized percutaneou nonfatal stroke committee signi american hospitalization